COVID Resource Center Newsroom

In an article exploring the low prevalence of flu cases, Dr. Binnicker was among the experts consulted on why influenza is so scarce this year.

Jane Hermansen of Mayo Clinic Labs weighs in on a discussion of uses for expanded testing capacity after the pandemic is over.

An article authored by Jane Hermansen of Mayo Clinic Labs considers how the experiences of the pandemic will shape the lab industry in years to come.

Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic Laboratories.

Viral online posts claimed the World Health Organization changed its COVID-19 testing guidelines and admitted to inflating case counts. Dr. Binnicker helps explain why those claims are false.

Mayo Clinic Laboratories now offers multiplex testing for SARS-CoV-2 (the virus that causes COVID-19) and influenza A and B to all health care providers. This test is used to detect and differentiate between COVID-19 and influenza A and B in a single test using upper respiratory tract specimens.

At the beginning of the pandemic, pooled testing was seen as a way to potentially conserve valuable testing resources, but logistical hurdles and other challenges have limited its usefulness.

Beginning Jan. 26, all air travelers entering the U.S. from other countries will need a negative COVID-19 test result before they can board their flights.

Dr. Matthew Binnicker addresses the dramatic decrease in flu cases, and the corresponding drop in serious illness and death related to influenza, seen throughout the country this year.

Mayo Clinic Laboratories is carefully monitoring the emergence of two new variants of SARS-CoV-2 ― the virus that causes COVID-19 ― in the U.S. One variant is from the U.K. and one variant is from South Africa.

Amir Sadighi Akha, M.D., D.Phil., lab section director for Mayo Clinic's Cellular and Molecular Immunology Laboratory, joins this episode of the "Answers From the Lab" podcast. Dr. Sadighi Akha and Bobbi Pritt, M.D., discuss dendritic cell enumeration — a new test offered through Mayo Clinic Laboratories that is the only clinical test of its kind currently available in the U.S.

A massive effort that involved numerous departments and experts, culminated in Mayo Clinic designing, testing and mass-manufacturing a 3D-printed mid-turbinate swab for COVID-19 testing.

On the podcast, Dr. William Morice described how Mayo Clinic Laboratories quickly ramped up to meet pandemic testing needs.